This guideline updates recommendations for prevention and treatment of glucocorticoid-induced osteoporosis (GIOP) for patients with rheumatic or nonrheumatic conditions receiving >3 months treatment with glucocorticoids (GCs) ≥2.5 mg daily. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.